Sign Up
OverviewAPI
The University of Washington’s Institute for Protein Design (IPD) is propelling startups like Xaira Therapeutics, co-founded by IPD head David Baker, with significant investor backing. IPD's AI-driven protein design tools are catalyzing innovations in therapeutics, vaccines, and materials. Their recent studies encompass antibody design, biomaterials, protein crystals, and novel proteins.

Ask a question